Illustration: Sarah Grillo/Axios
Carlyle is in talks to buy medical device giant Baxter's kidney care spinoff Vantive for more than $4 billion, including debt, WSJ reports.
Why it's the BFD: Large-scale LBOs are still few and far between, particularly in health care, where private equity is being scrutinized closely.
